Results 231 to 240 of about 52,189 (266)
Some of the next articles are maybe not open access.
CD19‐CAR engineered NK‐92 cells are sufficient to overcome NK cell resistance in B‐cell malignancies
Journal of Cellular and Molecular Medicine, 2016Oliver Ottmann +2 more
exaly
Diphtheria toxin‐based anti‐human CD19 immunotoxin for targeting human CD19+ tumors
Molecular Oncology, 2017Christene A Huang +2 more
exaly
CD19 regulates B lymphocyte responses to transmembrane signals
Seminars in Immunology, 1998Manabu Fujimoto +2 more
exaly
Functional dissection of the CD21/CD19/TAPA-1/Leu-13 complex of B lymphocytes.
Journal of Experimental Medicine, 1993Fearon D T, Klickstein L B, Ahearn J M
exaly
Antigen binding molecules specific for an anti-CD19 scFV
2020WILTZIUS JED, SIEVERS STUART
openaire +3 more sources
ANTIBODIES AND CHIMERIC ANTIGEN RECEPTORS SPECIFIC FOR CD19
2016CHEN YAN +3 more
openaire +7 more sources
CD19 SPECIFIC CHIMERIC ANTIGEN RECEPTOR AND USES THEREOF
2014GALETTO ROMAN +3 more
openaire +13 more sources
COMBINED CHIMERIC ANTIGEN RECEPTOR TARGETING CD19 AND CD20 AND APPLICATIONS THEREOF
2021YAO YIHONG +5 more
openaire +7 more sources
Human CD19-Targeted Mouse T Cells Induce B Cell Aplasia and Toxicity in Human CD19 Transgenic Mice
Molecular Therapy, 2018Michael Jensen +2 more
exaly